Carolyn Bertozzi earned her AB in Chemistry from Harvard University in 1988 and her PhD in Chemistry from the University of California, Berkeley in 1993, followed by postdoctoral training in immunology at UC San Francisco. She joined the Chemistry faculty at UC Berkeley in 1996, where she served as professor for 19 years until 2015. During this period, she directed the Molecular Foundry from 2006 to 2010 and helped establish a chemical biology major in the chemistry department. In 2015, Bertozzi joined Stanford University as the Anne T. and Robert M. Bass Professor of Chemistry in the School of Humanities and Sciences, Baker Family Director of Sarafan ChEM-H, and professor by courtesy of Chemical and Systems Biology and Radiology. She has been a Howard Hughes Medical Institute Investigator since 2000.

Bertozzi's research focuses on disease-associated glycobiology and the development of therapeutic modalities targeting these pathways through bioorthogonal chemistries for in vivo imaging and bioconjugation. Her inventions include next-generation antibody-drug conjugates, lysosome-targeting chimeras (LYTACs), antibody-enzyme conjugates, and antibody-lectin chimeras, several of which have progressed to clinical candidates for cancer and autoimmune diseases. Key publications comprise "Cell surface engineering by a modified Staudinger reaction" (Science, 2000), "Chemical glycobiology" (Science, 2001), "Copper-free click chemistry for dynamic in vivo imaging" (Proceedings of the National Academy of Sciences, 2007), "A strain-promoted [3+2] azide−alkyne cycloaddition for covalent modification of biomolecules in living systems" (Journal of the American Chemical Society, 2004), and "Bioorthogonal chemistry: fishing for selectivity in a sea of functionality" (Angewandte Chemie International Edition, 2009). She received the 2022 Nobel Prize in Chemistry for bioorthogonal chemistry. Additional honors include the Priestley Medal of the American Chemical Society, Welch Award in Chemistry, Wolf Prize in Chemistry, Heineken Prize, Lemelson-MIT Prize, and MacArthur Fellowship. Bertozzi is an elected member of the National Academy of Sciences, National Academy of Medicine, National Academy of Engineering, American Academy of Arts and Sciences, German Academy of Sciences Leopoldina, and Foreign Fellow of the Royal Society. Her innovations have revolutionized chemical biology, enabling precise interrogation of biomolecules in living organisms and advancing novel therapies.

Professional Email: bertozzi@stanford.edu